A Phase II Study with Lead‐In Safety Cohort of 5‐Fluorouracil, Oxaliplatin, and Lapatinib in Combination with Radiation Therapy as Neoadjuvant Treatment for Patients with Localized HER2‐Positive Esophagogastric Adenocarcinomas - Shepard, Gregg; Arrowsmith, Edward R.; Murphy, Patrick; Barton, John H.; Peyton, James D.; Mainwaring, Mark; Blakely, Laura; Maun, Noel A.; Bendell, Johanna C. (The oncologist (Dayton, Ohio), 2017)
Keywords: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols - pharmacology; Antineoplastic Combined Chemotherapy Protocols - therapeutic use; Clinical Trial Results; Esophageal Neoplasms - drug therapy; Esophageal Neoplasms - pathology; Female; Fluorouracil - pharmacology; Fluorouracil - therapeutic use; Humans; Male; Middle Aged; Neoadjuvant Therapy - methods; Organoplatinum Compounds - pharmacology; Organoplatinum Compounds - therapeutic use; Quinazolines - pharmacology; Quinazolines - therapeutic use; Stomach Neoplasms - drug therapy; Stomach Neoplasms - pathology